Imagine a promising biotech company, poised to revolutionize treatment for a debilitating skin condition, only to see its stock value obliterated overnight by disappointing trial results. This is the reality for Moonlake Immunotherapeutics, a Swiss-based firm that witnessed an 80% plunge in its
Imagine a world where a single protein could unlock the secrets to halting leukemia, a devastating blood cancer that claims countless lives each year, and bring hope to millions through groundbreaking advancements. This is not a distant dream but a tangible possibility with the discovery of
Imagine a world where a single injection in the arm could halt the progression of a debilitating eye condition like age-related macular degeneration (AMD), a disease that affects nearly 200 million people globally and stands as a leading cause of vision loss among those over 60. This vision is
For countless families touched by Huntington’s disease (HD), a genetic neurodegenerative disorder with no cure or disease-modifying treatments, the struggle against an inevitable decline has been a heartbreaking reality, but a beacon of hope emerged on September 24, 2025. On that date, uniQure
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose deep knowledge of technology and innovation in the industry has positioned him as a leading voice in research and development. Today, we’re diving into the fascinating study of Maria Branyas Morera, who lived to the
Imagine a world where a devastating, inherited brain disorder that robs individuals of their ability to move, think, and live independently could be slowed dramatically with a single medical intervention. Huntington's disease, a fatal neurodegenerative condition caused by a defect in the HTT gene,
